Overview

CKD-828 Drug Interaction Study (Telmisartan)

Status:
Completed

Trial end date:
2011-09-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the Pharmacokinetic drug interaction and safety of Telmisartan between free combination of Telmisartan and S-amlodipine and Telmisartan monotherapy.

Phase:

Phase 1

Details

Lead Sponsor:

Chong Kun Dang Pharmaceutical

Collaborator:

Asan Medical Center

Treatments:

Amlodipine
Telmisartan